A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: Insights from the GALACTIC-HF trial
European Journal of Heart Failure
Docherty KF, et al
January 4, 2023
Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy
Scientific Reports
Sharpe AN, et al
January 2, 2023
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology
Maron MS, et al
January 3, 2023
ENCALS Predictive Survival Model in FORTITUDE-ALS
Poster, 33rd International Symposium on ALS/MND
Simkins T, et al
Virtual
December 8, 2022
Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy
Journal of Invasive Cardiology
Butzner, M, et al
December 2022